Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome. Clinics, [S. l.], v. 68, n. 3, p. 339–343, 2013. DOI: 10.1590/clin.v68i3.72131. Disponível em: https://www.revistas.usp.br/clinics/article/view/72131.. Acesso em: 14 may. 2024.